Xencor (XNCR) Interest Coverage Ratio (2013 - 2026)
Xencor (XNCR) posted quarterly Interest Coverage Ratio of 0.85 for Q1 2026, up 83.02% year-over-year from 0.46 in Q1 2025, and up 96.09% quarter-over-quarter from 21.66 in Q4 2025.
Powered by 
Analysis
Xencor (XNCR) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Interest Coverage Ratio for 14 consecutive years, with 0.85 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 83.02% year-over-year to 0.85; the TTM figure through Mar 2026 stood at 2.31 (up 72.92% YoY), while the FY2025 annual figure was 1.88, down 138.99% from the prior year.
- Interest Coverage Ratio rose to 0.85 in Q1 2026 per XNCR's latest filing, from 21.66 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 38.69 in Q1 2022 and bottomed at 83.9 in Q1 2023.
- Historically, Interest Coverage Ratio has averaged 6.07 across 5 years, with a median of 1.42 in 2022.
- On a YoY basis, Interest Coverage Ratio climbed as much as 223.2% in 2022 and fell as far as 718.29% in 2022.
- Xencor's Interest Coverage Ratio stood at 14.91 in 2022, then soared by 53.12% to 6.99 in 2023, then soared by 171.23% to 4.98 in 2024, then slumped by 534.89% to 21.66 in 2025, then surged by 96.09% to 0.85 in 2026.
- Business Quant data shows XNCR's Interest Coverage Ratio at 0.85 in Q1 2026, 21.66 in Q4 2025, and 0.49 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | -5.04 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.04 |
| Mar 31, 2026 | -16.57 |
| Dec 31, 2025 | -7.29 |
| Sep 30, 2025 | -6.20 |
| Jun 30, 2025 | -4.02 |
| Mar 31, 2025 | -4.98 |
| Dec 31, 2024 | -1.52 |
| Sep 30, 2024 | -6.12 |
| Jun 30, 2024 | -5.97 |
| Mar 31, 2024 | -5.65 |
| Dec 31, 2023 | -4.44 |
| Sep 30, 2023 | -2,610.00 |
| Jun 30, 2023 | -3,713.86 |
| Mar 31, 2023 | -8,677.71 |
| Jun 30, 2018 | -9,430.00 |
| Mar 31, 2018 | -7,662.25 |
| Dec 31, 2017 | 1,065.20 |
| Sep 30, 2017 | -7,860.00 |
| Jun 30, 2017 | -2,836.67 |
| Mar 31, 2017 | -5,453.00 |